189 related articles for article (PubMed ID: 4811964)
1. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
Nicholson A; Brade V; Lee GD; Shin HS; Mayer MM
J Immunol; 1974 Mar; 112(3):1115-23. PubMed ID: 4811964
[No Abstract] [Full Text] [Related]
2. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
[No Abstract] [Full Text] [Related]
3. Anaphylatoxin formation by contact activation of plasma. 3. Fixation of two different anaphylatoxin-forming complexes on zymosan.
Brade V; Schmidt G; Vogt W
Eur J Immunol; 1972 Apr; 2(2):180-6. PubMed ID: 4644242
[No Abstract] [Full Text] [Related]
4. Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
Brade V; Nicholson A; Bitter-Suermann D; Hadding U
J Immunol; 1974 Dec; 113(6):1735-43. PubMed ID: 4279261
[No Abstract] [Full Text] [Related]
5. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
Stitzel AE; Spitzer RE
J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
[No Abstract] [Full Text] [Related]
6. The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule.
Winkelstein JA; Shin HS
J Immunol; 1974 May; 112(5):1635-42. PubMed ID: 4150446
[No Abstract] [Full Text] [Related]
7. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.
Vogt W; Schmidt G; Dieminger L; Lynen R
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):440-55. PubMed ID: 126576
[TBL] [Abstract][Full Text] [Related]
8. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
Brade V; Vogt W
Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
[No Abstract] [Full Text] [Related]
9. Interaction of C3b, B, and D in the alternative pathway of complement activation.
Nicholson A; Brade V; Schorlemmer HU; Burger R; Bitter-Suermann D; Hadding U
J Immunol; 1975 Oct; 115(4):1108-13. PubMed ID: 240884
[TBL] [Abstract][Full Text] [Related]
10. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.
Brade V; Bentley C; Bitter-Suermann D; Hadding U
Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):402-14. PubMed ID: 556571
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of Guinea pig properidin.
Nicholson A; Austen KF
J Immunol; 1977 Jan; 118(1):103-8. PubMed ID: 830742
[TBL] [Abstract][Full Text] [Related]
12. Changes in the immunochemical properties of highly purified properdin in human serum.
Minta JO
J Immunol; 1975 Apr; 114(4):1415-21. PubMed ID: 123262
[TBL] [Abstract][Full Text] [Related]
13. Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action.
Koethe SM; Austen KF; Gigli I
J Immunol; 1973 Feb; 110(2):390-400. PubMed ID: 4684033
[No Abstract] [Full Text] [Related]
14. Changes in antigenic properties of human C3 upon activation and conversion by trypsin.
Molenaar JL; Müller MA; Engelfriet CP; Pondman KW
J Immunol; 1974 Apr; 112(4):1444-51. PubMed ID: 4205530
[No Abstract] [Full Text] [Related]
15. Platelet injury due to activation of the alternate complement pathway.
Siraganian RP; Sandberg AL; Alexander A; Osler AG
J Immunol; 1973 Feb; 110(2):490-7. PubMed ID: 4119252
[No Abstract] [Full Text] [Related]
16. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
Brade V; Nicholson A; Lee GD; Mayer MM
J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
[No Abstract] [Full Text] [Related]
17. Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.
Goldlust MB; Shin HS; Hammer CH; Mayer MM
J Immunol; 1974 Sep; 113(3):998-1007. PubMed ID: 4213402
[No Abstract] [Full Text] [Related]
18. The first component of human complement (C1): kinetics of reaction with its natural substrates.
Strunk R; Colten HR
J Immunol; 1974 Mar; 112(3):905-10. PubMed ID: 4811969
[No Abstract] [Full Text] [Related]
19. [Properdin research. 1. Review of the properdin system and its problems; determination possibilities, assay of sera with high titer levels].
Zimmermann G
Arch Exp Veterinarmed; 1972; 26(2):221-46. PubMed ID: 4562974
[No Abstract] [Full Text] [Related]
20. Role of complement in immune lysis of Trypanosoma cruzi.
Anziano DF; Dalmasso AP; Lelchuk R; Vásquez C
Infect Immun; 1972 Nov; 6(5):860-4. PubMed ID: 4564786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
